ICD-10 Code B48.0 | Lobomycosis Symptoms, Diagnosis, Billing

Lobomycosis is a chronic fungal infection caused by the organism Loboa loboi, primarily affecting the skin and subcutaneous tissues. It is endemic in certain tropical regions and can lead to significant morbidity if left untreated. Accurate coding with ICD-10 Code B48.0 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and track this condition.

What is ICD-10 Code B48.0 for Lobomycosis?

ICD-10 Code B48.0 specifically represents Lobomycosis, a fungal infection characterized by the formation of nodular lesions on the skin. This code should be used in clinical documentation and billing when diagnosing patients with this condition, ensuring that healthcare providers can accurately capture the disease's nature and its impact on patient health.

ICD-10 Code B48.0 – Clinical Definition and Explanation of Lobomycosis

Lobomycosis is caused by the fungal pathogen Loboa loboi, which typically manifests as cutaneous lesions that can progress to more severe forms if untreated. The condition requires medical attention to prevent complications and improve patient outcomes.

Key Clinical Features:

• Nodular lesions on the skin, often resembling keloids.
• Lesions may be painless but can become infected.
• Commonly found in individuals with a history of exposure to freshwater environments.
• Chronic progression can lead to significant disfigurement.

ICD-10 Code B48.0 for Lobomycosis – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code B48.0 is utilized to document the diagnosis of Lobomycosis, aiding in the assessment of symptoms, clinical findings, and treatment plans. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code B48.0 for Lobomycosis Mean in SOAP Notes?

ICD-10 Code B48.0 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Lobomycosis. This code is crucial for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code B48.0 – Lobomycosis

Lobomycosis requires prompt medical intervention to prevent complications and manage symptoms effectively.

Antibiotic Therapy:

• Itraconazole: 200 mg daily for 6-12 months.
• Fluconazole: 400 mg daily as an alternative.
• Surgical excision may be necessary for extensive lesions.

Supportive Care:

• Regular monitoring of lesions for signs of infection.
• Pain management as needed.
• Patient education on skin care and hygiene.

Infection Control:

• Avoid close contact with infected individuals.
• Implement standard precautions in clinical settings.
• Educate patients on preventing exposure to contaminated water.

How to Document Symptoms of Lobomycosis (ICD-10 B48.0) in SOAP Notes

Subjective:

• Patient reports painless nodular lesions on the skin.
• History of exposure to freshwater environments.
• No significant pain or itching associated with lesions.
• Patient expresses concern about cosmetic appearance.

Objective:

• Physical examination reveals multiple nodular lesions on the extremities.
• Lesions are firm, non-tender, and well-defined.
• No signs of acute inflammation or secondary infection.
• Vital signs within normal limits.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Lobomycosis (ICD-10 Code B48.0)

Assessment:

• Diagnosis: Lobomycosis (ICD-10 B48.0), moderate severity.
• No relevant subcodes applicable.
• Contributing factors: History of freshwater exposure.

Plan:

• Initiate treatment with itraconazole 200 mg daily.
• Educate patient on skin care and hygiene practices.
• Schedule follow-up in 4 weeks to assess treatment response.
• Consider referral to dermatology for extensive lesions.

Treatment & Plan Section for ICD-10 Code B48.0 – Lobomycosis

• First-line treatment with itraconazole or fluconazole.
• Surgical intervention for large or symptomatic lesions.
• Patient education on hygiene and skin care.
• Regular follow-up to monitor treatment efficacy.

Using ICD-10 Code B48.0 for Lobomycosis in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings.
• Use B48.0 in appropriate clinical settings for billing.
• Align treatment plans with clinical guidelines for justified billing.
• Document all relevant patient education and follow-up plans.

Related ICD-10 Codes Often Used with Lobomycosis

• B38.0 – Coccidioidomycosis
• B44.9 – Aspergillosis, unspecified
• B45.9 – Histoplasmosis, unspecified
• B46.9 – Blastomycosis, unspecified

ICD-10 Code B48.0 in Medical Billing and Insurance for Lobomycosis

ICD-10 Code B48.0 is critical for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant patient history and clinical findings.
• Use B48.0 in conjunction with other codes as necessary.
• Ensure compliance with payer requirements for documentation.

Common CPT Pairings: